LONG-TERM DRUG SURVIVAL AND CAUSES OF DISCONTINUATION OF SUBCUTANEOUS ABATACEPT IN RHEUMATOID ARTHRITIS: 32-MONTH RESULTS FROM A PROSPECTIVE COHORT STUDY